nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—CYP3A4—Topotecan—ovarian cancer	0.0922	0.354	CbGbCtD
Conivaptan—CYP3A4—Vinorelbine—ovarian cancer	0.065	0.25	CbGbCtD
Conivaptan—CYP3A4—Paclitaxel—ovarian cancer	0.0457	0.175	CbGbCtD
Conivaptan—CYP3A4—Docetaxel—ovarian cancer	0.033	0.127	CbGbCtD
Conivaptan—CYP3A4—Doxorubicin—ovarian cancer	0.0246	0.0945	CbGbCtD
Conivaptan—Lomitapide—ABCB1—ovarian cancer	0.00696	0.43	CrCbGaD
Conivaptan—Tolvaptan—ABCB1—ovarian cancer	0.00621	0.383	CrCbGaD
Conivaptan—Candida infection—Paclitaxel—ovarian cancer	0.00442	0.00611	CcSEcCtD
Conivaptan—Urine output increased—Paclitaxel—ovarian cancer	0.00418	0.00578	CcSEcCtD
Conivaptan—Oral candidiasis—Epirubicin—ovarian cancer	0.00416	0.00576	CcSEcCtD
Conivaptan—Hypomagnesaemia—Epirubicin—ovarian cancer	0.00416	0.00576	CcSEcCtD
Conivaptan—Sepsis—Paclitaxel—ovarian cancer	0.00402	0.00555	CcSEcCtD
Conivaptan—Urinary tract disorder—Melphalan—ovarian cancer	0.00391	0.0054	CcSEcCtD
Conivaptan—Phlebitis—Paclitaxel—ovarian cancer	0.0039	0.00539	CcSEcCtD
Conivaptan—Urethral disorder—Melphalan—ovarian cancer	0.00388	0.00536	CcSEcCtD
Conivaptan—Pneumonia—Vinorelbine—ovarian cancer	0.00387	0.00535	CcSEcCtD
Conivaptan—Hypomagnesaemia—Doxorubicin—ovarian cancer	0.00385	0.00533	CcSEcCtD
Conivaptan—Oral candidiasis—Doxorubicin—ovarian cancer	0.00385	0.00533	CcSEcCtD
Conivaptan—Infestation NOS—Vinorelbine—ovarian cancer	0.00385	0.00532	CcSEcCtD
Conivaptan—Infestation—Vinorelbine—ovarian cancer	0.00385	0.00532	CcSEcCtD
Conivaptan—Polyuria—Paclitaxel—ovarian cancer	0.00383	0.00529	CcSEcCtD
Conivaptan—Candida infection—Docetaxel—ovarian cancer	0.00374	0.00518	CcSEcCtD
Conivaptan—Angiopathy—Topotecan—ovarian cancer	0.00366	0.00507	CcSEcCtD
Conivaptan—Anaemia—Chlorambucil—ovarian cancer	0.00365	0.00505	CcSEcCtD
Conivaptan—Mediastinal disorder—Topotecan—ovarian cancer	0.00364	0.00503	CcSEcCtD
Conivaptan—Mediastinal disorder—Melphalan—ovarian cancer	0.00356	0.00493	CcSEcCtD
Conivaptan—Atrial fibrillation—Paclitaxel—ovarian cancer	0.00354	0.0049	CcSEcCtD
Conivaptan—Malnutrition—Topotecan—ovarian cancer	0.00352	0.00486	CcSEcCtD
Conivaptan—Hypoglycaemia—Paclitaxel—ovarian cancer	0.00344	0.00476	CcSEcCtD
Conivaptan—Cardiac failure—Paclitaxel—ovarian cancer	0.00344	0.00476	CcSEcCtD
Conivaptan—Sepsis—Docetaxel—ovarian cancer	0.0034	0.0047	CcSEcCtD
Conivaptan—Hyponatraemia—Paclitaxel—ovarian cancer	0.00337	0.00466	CcSEcCtD
Conivaptan—Phlebitis—Docetaxel—ovarian cancer	0.0033	0.00457	CcSEcCtD
Conivaptan—Confusional state—Chlorambucil—ovarian cancer	0.00325	0.00449	CcSEcCtD
Conivaptan—Anaemia—Topotecan—ovarian cancer	0.00325	0.00449	CcSEcCtD
Conivaptan—Cardiac disorder—Vinorelbine—ovarian cancer	0.00321	0.00443	CcSEcCtD
Conivaptan—Infection—Chlorambucil—ovarian cancer	0.0032	0.00443	CcSEcCtD
Conivaptan—Anaemia—Melphalan—ovarian cancer	0.00318	0.0044	CcSEcCtD
Conivaptan—Angiopathy—Vinorelbine—ovarian cancer	0.00313	0.00433	CcSEcCtD
Conivaptan—Dehydration—Paclitaxel—ovarian cancer	0.00312	0.00432	CcSEcCtD
Conivaptan—Mediastinal disorder—Vinorelbine—ovarian cancer	0.00311	0.0043	CcSEcCtD
Conivaptan—Orthostatic hypotension—Paclitaxel—ovarian cancer	0.00307	0.00424	CcSEcCtD
Conivaptan—Hypokalaemia—Paclitaxel—ovarian cancer	0.00306	0.00423	CcSEcCtD
Conivaptan—Atorvastatin—ABCB1—ovarian cancer	0.00303	0.187	CrCbGaD
Conivaptan—Erythema—Vinorelbine—ovarian cancer	0.00301	0.00416	CcSEcCtD
Conivaptan—Malnutrition—Vinorelbine—ovarian cancer	0.00301	0.00416	CcSEcCtD
Conivaptan—Atrial fibrillation—Docetaxel—ovarian cancer	0.003	0.00415	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00297	0.00411	CcSEcCtD
Conivaptan—Cardiac failure—Docetaxel—ovarian cancer	0.00292	0.00403	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00291	0.00402	CcSEcCtD
Conivaptan—Hyponatraemia—Docetaxel—ovarian cancer	0.00286	0.00395	CcSEcCtD
Conivaptan—Infection—Topotecan—ovarian cancer	0.00285	0.00394	CcSEcCtD
Conivaptan—Nervous system disorder—Topotecan—ovarian cancer	0.00281	0.00389	CcSEcCtD
Conivaptan—Infection—Melphalan—ovarian cancer	0.00279	0.00386	CcSEcCtD
Conivaptan—Skin disorder—Topotecan—ovarian cancer	0.00279	0.00385	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00278	0.00385	CcSEcCtD
Conivaptan—Anaemia—Vinorelbine—ovarian cancer	0.00278	0.00384	CcSEcCtD
Conivaptan—Pain—Chlorambucil—ovarian cancer	0.00276	0.00381	CcSEcCtD
Conivaptan—Skin disorder—Melphalan—ovarian cancer	0.00273	0.00377	CcSEcCtD
Conivaptan—Pollakiuria—Paclitaxel—ovarian cancer	0.00268	0.00371	CcSEcCtD
Conivaptan—Feeling abnormal—Chlorambucil—ovarian cancer	0.00266	0.00367	CcSEcCtD
Conivaptan—Dehydration—Docetaxel—ovarian cancer	0.00265	0.00366	CcSEcCtD
Conivaptan—Hypotension—Melphalan—ovarian cancer	0.00263	0.00363	CcSEcCtD
Conivaptan—Hyperglycaemia—Paclitaxel—ovarian cancer	0.00262	0.00362	CcSEcCtD
Conivaptan—Pneumonia—Paclitaxel—ovarian cancer	0.0026	0.0036	CcSEcCtD
Conivaptan—Orthostatic hypotension—Docetaxel—ovarian cancer	0.0026	0.00359	CcSEcCtD
Conivaptan—Hypertension—Vinorelbine—ovarian cancer	0.0026	0.00359	CcSEcCtD
Conivaptan—Infestation NOS—Paclitaxel—ovarian cancer	0.00259	0.00358	CcSEcCtD
Conivaptan—Infestation—Paclitaxel—ovarian cancer	0.00259	0.00358	CcSEcCtD
Conivaptan—Body temperature increased—Chlorambucil—ovarian cancer	0.00255	0.00352	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00254	0.00351	CcSEcCtD
Conivaptan—Candida infection—Epirubicin—ovarian cancer	0.00253	0.00349	CcSEcCtD
Conivaptan—Urinary tract infection—Paclitaxel—ovarian cancer	0.00252	0.00348	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00248	0.00342	CcSEcCtD
Conivaptan—Haematuria—Paclitaxel—ovarian cancer	0.00247	0.00341	CcSEcCtD
Conivaptan—Pain—Topotecan—ovarian cancer	0.00245	0.00339	CcSEcCtD
Conivaptan—Constipation—Topotecan—ovarian cancer	0.00245	0.00339	CcSEcCtD
Conivaptan—Infection—Vinorelbine—ovarian cancer	0.00244	0.00337	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00243	0.00335	CcSEcCtD
Conivaptan—Nervous system disorder—Vinorelbine—ovarian cancer	0.00241	0.00333	CcSEcCtD
Conivaptan—Pain—Melphalan—ovarian cancer	0.0024	0.00332	CcSEcCtD
Conivaptan—Skin disorder—Vinorelbine—ovarian cancer	0.00238	0.0033	CcSEcCtD
Conivaptan—Feeling abnormal—Topotecan—ovarian cancer	0.00236	0.00327	CcSEcCtD
Conivaptan—Candida infection—Doxorubicin—ovarian cancer	0.00234	0.00323	CcSEcCtD
Conivaptan—Sepsis—Epirubicin—ovarian cancer	0.0023	0.00317	CcSEcCtD
Conivaptan—Urinary tract disorder—Paclitaxel—ovarian cancer	0.00229	0.00317	CcSEcCtD
Conivaptan—Hypotension—Vinorelbine—ovarian cancer	0.00229	0.00317	CcSEcCtD
Conivaptan—Oedema peripheral—Paclitaxel—ovarian cancer	0.00229	0.00316	CcSEcCtD
Conivaptan—Pruritus—Chlorambucil—ovarian cancer	0.00228	0.00315	CcSEcCtD
Conivaptan—Urethral disorder—Paclitaxel—ovarian cancer	0.00228	0.00315	CcSEcCtD
Conivaptan—Body temperature increased—Topotecan—ovarian cancer	0.00227	0.00314	CcSEcCtD
Conivaptan—Phlebitis—Epirubicin—ovarian cancer	0.00223	0.00308	CcSEcCtD
Conivaptan—Pneumonia—Docetaxel—ovarian cancer	0.00221	0.00305	CcSEcCtD
Conivaptan—Diarrhoea—Chlorambucil—ovarian cancer	0.00221	0.00305	CcSEcCtD
Conivaptan—Infestation—Docetaxel—ovarian cancer	0.00219	0.00303	CcSEcCtD
Conivaptan—Infestation NOS—Docetaxel—ovarian cancer	0.00219	0.00303	CcSEcCtD
Conivaptan—Cardiac disorder—Paclitaxel—ovarian cancer	0.00216	0.00298	CcSEcCtD
Conivaptan—Sepsis—Doxorubicin—ovarian cancer	0.00212	0.00294	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00212	0.00293	CcSEcCtD
Conivaptan—Angiopathy—Paclitaxel—ovarian cancer	0.00211	0.00291	CcSEcCtD
Conivaptan—Constipation—Vinorelbine—ovarian cancer	0.0021	0.0029	CcSEcCtD
Conivaptan—Pain—Vinorelbine—ovarian cancer	0.0021	0.0029	CcSEcCtD
Conivaptan—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00209	0.0029	CcSEcCtD
Conivaptan—Phlebitis—Doxorubicin—ovarian cancer	0.00206	0.00285	CcSEcCtD
Conivaptan—Vomiting—Chlorambucil—ovarian cancer	0.00205	0.00283	CcSEcCtD
Conivaptan—Mental disorder—Paclitaxel—ovarian cancer	0.00204	0.00281	CcSEcCtD
Conivaptan—Pruritus—Topotecan—ovarian cancer	0.00203	0.00281	CcSEcCtD
Conivaptan—Malnutrition—Paclitaxel—ovarian cancer	0.00202	0.0028	CcSEcCtD
Conivaptan—Erythema—Paclitaxel—ovarian cancer	0.00202	0.0028	CcSEcCtD
Conivaptan—Feeling abnormal—Vinorelbine—ovarian cancer	0.00202	0.0028	CcSEcCtD
Conivaptan—Pruritus—Melphalan—ovarian cancer	0.00199	0.00275	CcSEcCtD
Conivaptan—Hypoglycaemia—Epirubicin—ovarian cancer	0.00197	0.00272	CcSEcCtD
Conivaptan—Cardiac failure—Epirubicin—ovarian cancer	0.00197	0.00272	CcSEcCtD
Conivaptan—Diarrhoea—Topotecan—ovarian cancer	0.00196	0.00271	CcSEcCtD
Conivaptan—Urinary tract disorder—Docetaxel—ovarian cancer	0.00195	0.00269	CcSEcCtD
Conivaptan—Body temperature increased—Vinorelbine—ovarian cancer	0.00194	0.00268	CcSEcCtD
Conivaptan—Oedema peripheral—Docetaxel—ovarian cancer	0.00194	0.00268	CcSEcCtD
Conivaptan—Urethral disorder—Docetaxel—ovarian cancer	0.00193	0.00267	CcSEcCtD
Conivaptan—Hyponatraemia—Epirubicin—ovarian cancer	0.00193	0.00267	CcSEcCtD
Conivaptan—Diarrhoea—Melphalan—ovarian cancer	0.00192	0.00266	CcSEcCtD
Conivaptan—Nausea—Chlorambucil—ovarian cancer	0.00191	0.00265	CcSEcCtD
Conivaptan—Anaemia—Paclitaxel—ovarian cancer	0.00187	0.00258	CcSEcCtD
Conivaptan—Cardiac disorder—Docetaxel—ovarian cancer	0.00183	0.00253	CcSEcCtD
Conivaptan—Vomiting—Topotecan—ovarian cancer	0.00182	0.00252	CcSEcCtD
Conivaptan—Hypoglycaemia—Doxorubicin—ovarian cancer	0.00182	0.00252	CcSEcCtD
Conivaptan—Cardiac failure—Doxorubicin—ovarian cancer	0.00182	0.00252	CcSEcCtD
Conivaptan—Headache—Topotecan—ovarian cancer	0.0018	0.00248	CcSEcCtD
Conivaptan—Angiopathy—Docetaxel—ovarian cancer	0.00179	0.00247	CcSEcCtD
Conivaptan—Vomiting—Melphalan—ovarian cancer	0.00179	0.00247	CcSEcCtD
Conivaptan—Dehydration—Epirubicin—ovarian cancer	0.00179	0.00247	CcSEcCtD
Conivaptan—Hyponatraemia—Doxorubicin—ovarian cancer	0.00178	0.00247	CcSEcCtD
Conivaptan—Mediastinal disorder—Docetaxel—ovarian cancer	0.00178	0.00245	CcSEcCtD
Conivaptan—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00175	0.00242	CcSEcCtD
Conivaptan—Hypokalaemia—Epirubicin—ovarian cancer	0.00175	0.00242	CcSEcCtD
Conivaptan—Hypertension—Paclitaxel—ovarian cancer	0.00175	0.00241	CcSEcCtD
Conivaptan—Pruritus—Vinorelbine—ovarian cancer	0.00174	0.0024	CcSEcCtD
Conivaptan—Mental disorder—Docetaxel—ovarian cancer	0.00173	0.00239	CcSEcCtD
Conivaptan—Erythema—Docetaxel—ovarian cancer	0.00171	0.00237	CcSEcCtD
Conivaptan—Malnutrition—Docetaxel—ovarian cancer	0.00171	0.00237	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00171	0.00236	CcSEcCtD
Conivaptan—Nausea—Topotecan—ovarian cancer	0.0017	0.00236	CcSEcCtD
Conivaptan—Dry mouth—Paclitaxel—ovarian cancer	0.00168	0.00233	CcSEcCtD
Conivaptan—Diarrhoea—Vinorelbine—ovarian cancer	0.00168	0.00232	CcSEcCtD
Conivaptan—Nausea—Melphalan—ovarian cancer	0.00167	0.00231	CcSEcCtD
Conivaptan—Confusional state—Paclitaxel—ovarian cancer	0.00166	0.0023	CcSEcCtD
Conivaptan—Dehydration—Doxorubicin—ovarian cancer	0.00165	0.00228	CcSEcCtD
Conivaptan—Infection—Paclitaxel—ovarian cancer	0.00164	0.00227	CcSEcCtD
Conivaptan—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.00162	0.00224	CcSEcCtD
Conivaptan—Nervous system disorder—Paclitaxel—ovarian cancer	0.00162	0.00224	CcSEcCtD
Conivaptan—Hypokalaemia—Doxorubicin—ovarian cancer	0.00162	0.00224	CcSEcCtD
Conivaptan—Skin disorder—Paclitaxel—ovarian cancer	0.0016	0.00222	CcSEcCtD
Conivaptan—Anaemia—Docetaxel—ovarian cancer	0.00158	0.00219	CcSEcCtD
Conivaptan—Vomiting—Vinorelbine—ovarian cancer	0.00156	0.00216	CcSEcCtD
Conivaptan—Hypotension—Paclitaxel—ovarian cancer	0.00154	0.00213	CcSEcCtD
Conivaptan—Headache—Vinorelbine—ovarian cancer	0.00154	0.00213	CcSEcCtD
Conivaptan—Pollakiuria—Epirubicin—ovarian cancer	0.00153	0.00212	CcSEcCtD
Conivaptan—Hyperglycaemia—Epirubicin—ovarian cancer	0.0015	0.00207	CcSEcCtD
Conivaptan—Insomnia—Paclitaxel—ovarian cancer	0.00149	0.00206	CcSEcCtD
Conivaptan—Pneumonia—Epirubicin—ovarian cancer	0.00149	0.00206	CcSEcCtD
Conivaptan—Hypertension—Docetaxel—ovarian cancer	0.00148	0.00205	CcSEcCtD
Conivaptan—Infestation—Epirubicin—ovarian cancer	0.00148	0.00205	CcSEcCtD
Conivaptan—Infestation NOS—Epirubicin—ovarian cancer	0.00148	0.00205	CcSEcCtD
Conivaptan—Nausea—Vinorelbine—ovarian cancer	0.00146	0.00202	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00145	0.002	CcSEcCtD
Conivaptan—Urinary tract infection—Epirubicin—ovarian cancer	0.00144	0.00199	CcSEcCtD
Conivaptan—Dry mouth—Docetaxel—ovarian cancer	0.00143	0.00197	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00143	0.00197	CcSEcCtD
Conivaptan—Pollakiuria—Doxorubicin—ovarian cancer	0.00142	0.00196	CcSEcCtD
Conivaptan—Constipation—Paclitaxel—ovarian cancer	0.00141	0.00195	CcSEcCtD
Conivaptan—Pain—Paclitaxel—ovarian cancer	0.00141	0.00195	CcSEcCtD
Conivaptan—Haematuria—Epirubicin—ovarian cancer	0.00141	0.00195	CcSEcCtD
Conivaptan—Confusional state—Docetaxel—ovarian cancer	0.00141	0.00195	CcSEcCtD
Conivaptan—Infection—Docetaxel—ovarian cancer	0.00139	0.00192	CcSEcCtD
Conivaptan—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00139	0.00192	CcSEcCtD
Conivaptan—Pneumonia—Doxorubicin—ovarian cancer	0.00138	0.0019	CcSEcCtD
Conivaptan—Nervous system disorder—Docetaxel—ovarian cancer	0.00137	0.0019	CcSEcCtD
Conivaptan—Infestation NOS—Doxorubicin—ovarian cancer	0.00137	0.00189	CcSEcCtD
Conivaptan—Infestation—Doxorubicin—ovarian cancer	0.00137	0.00189	CcSEcCtD
Conivaptan—Feeling abnormal—Paclitaxel—ovarian cancer	0.00136	0.00188	CcSEcCtD
Conivaptan—Skin disorder—Docetaxel—ovarian cancer	0.00136	0.00188	CcSEcCtD
Conivaptan—Urinary tract infection—Doxorubicin—ovarian cancer	0.00133	0.00184	CcSEcCtD
Conivaptan—Urinary tract disorder—Epirubicin—ovarian cancer	0.00131	0.00181	CcSEcCtD
Conivaptan—Oedema peripheral—Epirubicin—ovarian cancer	0.00131	0.00181	CcSEcCtD
Conivaptan—Hypotension—Docetaxel—ovarian cancer	0.00131	0.00181	CcSEcCtD
Conivaptan—Haematuria—Doxorubicin—ovarian cancer	0.00131	0.0018	CcSEcCtD
Conivaptan—Body temperature increased—Paclitaxel—ovarian cancer	0.00131	0.0018	CcSEcCtD
Conivaptan—Urethral disorder—Epirubicin—ovarian cancer	0.0013	0.0018	CcSEcCtD
Conivaptan—Insomnia—Docetaxel—ovarian cancer	0.00127	0.00175	CcSEcCtD
Conivaptan—Cardiac disorder—Epirubicin—ovarian cancer	0.00123	0.0017	CcSEcCtD
Conivaptan—Urinary tract disorder—Doxorubicin—ovarian cancer	0.00121	0.00168	CcSEcCtD
Conivaptan—Oedema peripheral—Doxorubicin—ovarian cancer	0.00121	0.00167	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00121	0.00167	CcSEcCtD
Conivaptan—Angiopathy—Epirubicin—ovarian cancer	0.00121	0.00167	CcSEcCtD
Conivaptan—Urethral disorder—Doxorubicin—ovarian cancer	0.00121	0.00167	CcSEcCtD
Conivaptan—Mediastinal disorder—Epirubicin—ovarian cancer	0.0012	0.00166	CcSEcCtD
Conivaptan—Pain—Docetaxel—ovarian cancer	0.0012	0.00165	CcSEcCtD
Conivaptan—Constipation—Docetaxel—ovarian cancer	0.0012	0.00165	CcSEcCtD
Conivaptan—Pruritus—Paclitaxel—ovarian cancer	0.00117	0.00161	CcSEcCtD
Conivaptan—Mental disorder—Epirubicin—ovarian cancer	0.00116	0.00161	CcSEcCtD
Conivaptan—Erythema—Epirubicin—ovarian cancer	0.00116	0.0016	CcSEcCtD
Conivaptan—Malnutrition—Epirubicin—ovarian cancer	0.00116	0.0016	CcSEcCtD
Conivaptan—Feeling abnormal—Docetaxel—ovarian cancer	0.00115	0.00159	CcSEcCtD
Conivaptan—Cardiac disorder—Doxorubicin—ovarian cancer	0.00114	0.00158	CcSEcCtD
Conivaptan—Diarrhoea—Paclitaxel—ovarian cancer	0.00113	0.00156	CcSEcCtD
Conivaptan—Angiopathy—Doxorubicin—ovarian cancer	0.00112	0.00154	CcSEcCtD
Conivaptan—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00111	0.00153	CcSEcCtD
Conivaptan—Body temperature increased—Docetaxel—ovarian cancer	0.00111	0.00153	CcSEcCtD
Conivaptan—Mental disorder—Doxorubicin—ovarian cancer	0.00108	0.00149	CcSEcCtD
Conivaptan—Erythema—Doxorubicin—ovarian cancer	0.00107	0.00148	CcSEcCtD
Conivaptan—Malnutrition—Doxorubicin—ovarian cancer	0.00107	0.00148	CcSEcCtD
Conivaptan—Anaemia—Epirubicin—ovarian cancer	0.00107	0.00148	CcSEcCtD
Conivaptan—Vomiting—Paclitaxel—ovarian cancer	0.00105	0.00145	CcSEcCtD
Conivaptan—Headache—Paclitaxel—ovarian cancer	0.00103	0.00143	CcSEcCtD
Conivaptan—Hypertension—Epirubicin—ovarian cancer	0.000998	0.00138	CcSEcCtD
Conivaptan—Pruritus—Docetaxel—ovarian cancer	0.00099	0.00137	CcSEcCtD
Conivaptan—Anaemia—Doxorubicin—ovarian cancer	0.000989	0.00137	CcSEcCtD
Conivaptan—Nausea—Paclitaxel—ovarian cancer	0.000981	0.00136	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000978	0.00135	CcSEcCtD
Conivaptan—Dry mouth—Epirubicin—ovarian cancer	0.000963	0.00133	CcSEcCtD
Conivaptan—Diarrhoea—Docetaxel—ovarian cancer	0.000957	0.00132	CcSEcCtD
Conivaptan—Confusional state—Epirubicin—ovarian cancer	0.000952	0.00132	CcSEcCtD
Conivaptan—Infection—Epirubicin—ovarian cancer	0.000938	0.0013	CcSEcCtD
Conivaptan—Nervous system disorder—Epirubicin—ovarian cancer	0.000926	0.00128	CcSEcCtD
Conivaptan—Hypertension—Doxorubicin—ovarian cancer	0.000924	0.00128	CcSEcCtD
Conivaptan—Skin disorder—Epirubicin—ovarian cancer	0.000917	0.00127	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000905	0.00125	CcSEcCtD
Conivaptan—Dry mouth—Doxorubicin—ovarian cancer	0.000891	0.00123	CcSEcCtD
Conivaptan—Vomiting—Docetaxel—ovarian cancer	0.00089	0.00123	CcSEcCtD
Conivaptan—Hypotension—Epirubicin—ovarian cancer	0.000882	0.00122	CcSEcCtD
Conivaptan—Confusional state—Doxorubicin—ovarian cancer	0.000881	0.00122	CcSEcCtD
Conivaptan—Headache—Docetaxel—ovarian cancer	0.000877	0.00121	CcSEcCtD
Conivaptan—Infection—Doxorubicin—ovarian cancer	0.000868	0.0012	CcSEcCtD
Conivaptan—Nervous system disorder—Doxorubicin—ovarian cancer	0.000856	0.00118	CcSEcCtD
Conivaptan—Insomnia—Epirubicin—ovarian cancer	0.000854	0.00118	CcSEcCtD
Conivaptan—Skin disorder—Doxorubicin—ovarian cancer	0.000848	0.00117	CcSEcCtD
Conivaptan—Nausea—Docetaxel—ovarian cancer	0.000831	0.00115	CcSEcCtD
Conivaptan—Hypotension—Doxorubicin—ovarian cancer	0.000816	0.00113	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000815	0.00113	CcSEcCtD
Conivaptan—Constipation—Epirubicin—ovarian cancer	0.000807	0.00112	CcSEcCtD
Conivaptan—Pain—Epirubicin—ovarian cancer	0.000807	0.00112	CcSEcCtD
Conivaptan—Insomnia—Doxorubicin—ovarian cancer	0.00079	0.00109	CcSEcCtD
Conivaptan—Feeling abnormal—Epirubicin—ovarian cancer	0.000778	0.00108	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000754	0.00104	CcSEcCtD
Conivaptan—Constipation—Doxorubicin—ovarian cancer	0.000747	0.00103	CcSEcCtD
Conivaptan—Pain—Doxorubicin—ovarian cancer	0.000747	0.00103	CcSEcCtD
Conivaptan—Body temperature increased—Epirubicin—ovarian cancer	0.000746	0.00103	CcSEcCtD
Conivaptan—Feeling abnormal—Doxorubicin—ovarian cancer	0.00072	0.000995	CcSEcCtD
Conivaptan—Body temperature increased—Doxorubicin—ovarian cancer	0.00069	0.000954	CcSEcCtD
Conivaptan—Pruritus—Epirubicin—ovarian cancer	0.000668	0.000923	CcSEcCtD
Conivaptan—Diarrhoea—Epirubicin—ovarian cancer	0.000646	0.000893	CcSEcCtD
Conivaptan—Pruritus—Doxorubicin—ovarian cancer	0.000618	0.000854	CcSEcCtD
Conivaptan—Vomiting—Epirubicin—ovarian cancer	0.0006	0.00083	CcSEcCtD
Conivaptan—Diarrhoea—Doxorubicin—ovarian cancer	0.000598	0.000826	CcSEcCtD
Conivaptan—Headache—Epirubicin—ovarian cancer	0.000591	0.000817	CcSEcCtD
Conivaptan—Nausea—Epirubicin—ovarian cancer	0.000561	0.000775	CcSEcCtD
Conivaptan—Vomiting—Doxorubicin—ovarian cancer	0.000555	0.000768	CcSEcCtD
Conivaptan—Headache—Doxorubicin—ovarian cancer	0.000547	0.000756	CcSEcCtD
Conivaptan—Nausea—Doxorubicin—ovarian cancer	0.000519	0.000717	CcSEcCtD
